Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.850
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Fulcrum Therapeutics Employees
Fulcrum Therapeutics had 76 employees as of December 31, 2023. The number of employees decreased by 13 or -14.61% compared to the previous year.
Employees
76
Change (1Y)
-13
Growth (1Y)
-14.61%
Revenue / Employee
$1,064,092
Profits / Employee
-$235,697
Market Cap
207.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
FULC News
- 3 days ago - Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET - GlobeNewsWire
- 14 days ago - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 15 days ago - Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 3 months ago - Fulcrum Therapeutics to Participate in Upcoming December Conferences - GlobeNewsWire
- 3 months ago - Fulcrum Therapeutics, Inc. (FULC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference - GlobeNewsWire
- 3 months ago - Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET - GlobeNewsWire
- 4 months ago - FMR LLC's Strategic Reduction in Fulcrum Therapeutics Inc Shares - GuruFocus